Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3

Explore clinical trials studying Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma and Other Neuroendocrine Neoplasms Expressing DLL3 trial results

Recruiting

A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3

NCT04429087

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Winship Cancer Institute Atlanta, Georgia, United States
  • University of Maryland School of Medicine Baltimore, Maryland, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions